-       Report 
   - November 2023
    -  120 Pages 
    Europe
   
   From       €3595EUR$4,000USD£3,153GBP 
                -       Report 
   - March 2023
    -  116 Pages 
    Global
   
   From       €4045EUR$4,500USD£3,547GBP 
                -       Report 
   - December 2024
    -  80 Pages 
    India
   
   From       €3146EUR$3,500USD£2,759GBP 
                -       Report 
   - August 2024
    -  185 Pages 
    Global
   
   From       €4045EUR$4,500USD£3,547GBP 
                -       Report 
   - April 2023
    -  90 Pages 
    Middle East, Africa
   
   From       €4269EUR$4,750USD£3,744GBP 
                   -       Report 
   - August 2024
    -  150 Pages 
    Global
   
   From       €2696EUR$3,000USD£2,365GBP 
      €3371EUR$3,750USD£2,956GBP 
                  -       Report 
   - July 2024
    -  100 Pages 
    Global
   
   From       €2696EUR$3,000USD£2,365GBP 
      €3371EUR$3,750USD£2,956GBP 
                  -       Report 
   - July 2024
    -  150 Pages 
    Global
   
   From       €2696EUR$3,000USD£2,365GBP 
      €3371EUR$3,750USD£2,956GBP 
                  -       Report 
   - July 2024
    -  150 Pages 
    Global
   
   From       €2696EUR$3,000USD£2,365GBP 
      €3371EUR$3,750USD£2,956GBP 
                  -       Report 
   - July 2024
    -  150 Pages 
    Global
   
   From       €2696EUR$3,000USD£2,365GBP 
      €3371EUR$3,750USD£2,956GBP 
                  -       Report 
   - July 2024
    -  150 Pages 
    Global
   
   From       €2696EUR$3,000USD£2,365GBP 
      €3371EUR$3,750USD£2,956GBP 
                  -       Report 
   - July 2024
    -  150 Pages 
    Global
   
   From       €2696EUR$3,000USD£2,365GBP 
      €3371EUR$3,750USD£2,956GBP 
                  -       Report 
   - July 2024
    -  150 Pages 
    Global
   
   From       €2696EUR$3,000USD£2,365GBP 
      €3371EUR$3,750USD£2,956GBP 
                  -       Report 
   - July 2024
    -  100 Pages 
    Global
   
   From       €2696EUR$3,000USD£2,365GBP 
      €3371EUR$3,750USD£2,956GBP 
                  -       Report 
   - July 2024
    -  100 Pages 
    Global
   
   From       €2696EUR$3,000USD£2,365GBP 
      €3371EUR$3,750USD£2,956GBP 
                -       Report 
   - May 2024
    -  200 Pages 
    Global
   
   From       €3730EUR$4,150USD£3,271GBP 
                -       Report 
   - May 2024
    -  200 Pages 
    Global
   
   From       €3730EUR$4,150USD£3,271GBP 
                -       Report 
   - July 2023
    -  145 Pages 
    Global
   
   From       €2831EUR$3,150USD£2,483GBP 
                -       Report 
   - May 2025
    -  62 Pages 
    Brazil
   
   From       €4269EUR$4,750USD£3,744GBP 
                -       Report 
   - February 2024
    -  118 Pages 
    Global
   
   From       €4269EUR$4,750USD£3,744GBP 
             
         Severe Acute Respiratory Syndrome (SARS) is a contagious respiratory illness caused by a virus. Diagnostics for SARS involve laboratory tests to detect the virus or its genetic material in a sample taken from the patient. Diagnostic tests for SARS include reverse transcription-polymerase chain reaction (RT-PCR), antigen-capture enzyme-linked immunosorbent assay (ELISA), and nucleic acid hybridization. These tests are used to detect the presence of the virus in a patient's sample and to differentiate    between SARS and other respiratory illnesses.
Diagnostics for SARS are important for early detection and treatment of the disease. Early diagnosis and treatment can reduce the severity of the illness and prevent its spread. Diagnostics for SARS are also used to monitor the spread of the virus and to track its evolution.
Companies in the SARS diagnostics market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less   Read more